Higher intakes of dietary dicarbonyl compounds are associated with lower risk of cardiovascular disease
- PMID: 40036164
- PMCID: PMC12600303
- DOI: 10.1093/eurjpc/zwaf060
Higher intakes of dietary dicarbonyl compounds are associated with lower risk of cardiovascular disease
Abstract
Aims: Dicarbonyl compounds such as methylglyoxal (MGO), glyoxal (GO), and 3-deoxyglucosone (3-DG) are present in numerous foods. They are pro-inflammatory and pro-oxidative, but their potential role in cardiovascular disease (CVD) development has been scarcely studied. We explored associations between dietary dicarbonyls with fatal and non-fatal CVD.
Methods and results: We conducted a case-cohort analysis based on 32 873 subjects drawn from 346 055 participants of the multi-national prospective EPIC cohort. Cases (15 863 subjects) were CVD-free at baseline and later developed CVD [coronary heart disease (CHD) and/or stroke] with non-fatal (n CVD = 17 837; n CHD = 12 003; n stroke = 6791; not mutually exclusive) and/or fatal (n CVD = 2894; n CHD = 2284; n stroke = 908) outcomes. Dietary intake of dicarbonyl compounds was estimated using country-specific questionnaires linked to a food composition database of dicarbonyl compounds. Multivariable prentice weighted Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% CIs for incident non-fatal and fatal CVD. The main food sources of dicarbonyl compounds include cereals, sugar and confectionaries, coffee, fruits, and vegetables. Higher dietary dicarbonyl intakes were inversely associated with non-fatal CVD (per 1 SD increase, GO: HR = 0.95, 95% CI 0.92-0.98; 3-DG: HR = 0.95, 95% CI 0.92-0.98), fatal CVD (MGO: HR = 0.92, 95% CI 0.87-0.97; GO: HR = 0.91, 0.86-0.96; 3-DG: HR = 0.93, 0.86-0.99), non-fatal CHD (3-DG: HR = 0.95, 0.92-0.99), non-fatal stroke (MGO: HR = 0.93, 95% CI 0.90-0.96; GO: HR = 0.90, 95% CI 0.86-0.95; 3-DG: HR = 0.92, 95% CI 0.89-0.96), and fatal CHD (MGO: HR = 0.94, 95% CI 0.88-0.99; GO: HR = 0.92, 0.86-0.98; 3-DG: HR = 0.89, 0.82-0.96).
Conclusion: Higher intakes of dietary MGO, GO, and 3-DG intake are associated with lower risk of non-fatal or fatal CVD. Further research is required to confirm these findings, assess circulating levels of dicarbonyls, and explore potential underlying mechanisms for their observed CVD risk associations.
Lay summary: Dicarbonyl compounds are known to promote oxidative stress, inflammation, endothelial dysfunction, and vascular complications. They are formed endogenously in the body as a byproduct in glucose metabolism but are also present in some foods during food preparation and processing.We studied the role of three major dicarbonyl compounds coming from foods on cardiovascular diseases using data from the prospective EPIC cohort, which includes over 520 000 participants from 10 European countries.We observed that higher consumption of dietary dicarbonyl compounds resulted in a lower risk of non-fatal or fatal CVD.Our findings highlight the need to better understand the roles of these dietary compounds along with their potential underlying mechanisms of action.
Keywords: 3-deoxyglucosone; advanced glycation end products; cardiovascular disease; case-cohort study; glyoxal; methylglyoxal.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: none declared.
Comment in
-
Dietary dicarbonyl compounds: independently cardioprotective or beneficial by association?Eur J Prev Cardiol. 2025 Nov 11;32(16):1601-1602. doi: 10.1093/eurjpc/zwaf179. Eur J Prev Cardiol. 2025. PMID: 40135686 No abstract available.
References
-
- Hellwig M, Gensberger-Reigl S, Henle T, Pischetsrieder M. Food-derived 1,2-dicarbonyl compounds and their role in diseases. Semin Cancer Biol 2018;49:1–8. - PubMed
-
- Matafome P, Rodrigues T, Sena C, Seiça R. Methylglyoxal in metabolic disorders: facts, myths, and promises. Med Res Rev 2017;37:368–403. - PubMed
-
- Sibbersen C, Johannsen M. Dicarbonyl derived post-translational modifications: chemistry bridging biology and aging-related disease. Essays Biochem 2020;64:97–110. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Dutch ZON
- Instituto de Salud Carlos III
- Compagnia di SanPaolo and National Research Council
- Federal Ministry of Education and Research
- Danish Cancer Society
- Research Funds
- Catalan Institute of Oncology-ICO
- German Cancer Aid
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Health Research Fund Fondo de Investigaciones Sanitarias
- 001/WHO_/World Health Organization/International
- Ligue Contre le Cancer
- International Agency for Research on Cancer
- German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
- Netherlands Cancer Registry
- NIHR Imperial Biomedical Research Centre
- Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra
- CPII20/00009/'Miguel Servet II'
- Statistics Netherlands
- Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy
- The Swedish Research Council and County Councils of Skåne and Västerbotten
- Dutch Prevention Funds
- Institut National de la Santé et de la Recherche Médicale
- Dutch Ministry of Public Health, Welfare and Sports
- German Cancer Research Center
- World Cancer Research Fund
- A Healthy Diet for a Healthy Life'
- EU Horizon 2020 Research and Innovation Programme
- 727,565/ERA-NET Cofund HDHL INTIMIC
- Institut Gustave Roussy
- Mutuelle Générale de l'Education Nationale
- European Joint Programming Initiative 'A Healthy Diet for a Healthy Life'
- Health Research Fund
- 14136/CRUK_/Cancer Research UK/United Kingdom
- C8221/A29017/CRUK_/Cancer Research UK/United Kingdom
- 1000143/MRC_/Medical Research Council/United Kingdom
- MR/M012190/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
